Results 281 to 290 of about 39,021 (326)

Circulating Tumor DNA (ctDNA) in Gastroesophageal Adenocarcinoma (GEA): Evidence and Emerging Applications. [PDF]

Cancers (Basel)
Sahwan O, Batha L, Jamal F, Sonbol MB.
europepmc   +1 more source

Tumor-naïve multimodal profiling of circulating tumor DNA to detect minimal residual disease in solid tumors. [PDF]

Ther Adv Med Oncol
Nguyen T, Nguyen Hoang VA, Nguyen TH, Tran TH, Nguyen N, Le Vo TT, Nguyen DS, Giang H, Nguyen HN, Tu LN.   +9 more
europepmc   +1 more source

Figure 2 from Serially Quantifying <i>TERT</i> Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma

Jan F. Hollander, Annabell Szymansky, Jasmin Wünschel, Kathy Astrahantseff, Carolina Rosswog, Anne Thorwarth, Theresa M. Thole-Kliesch, Rocío Chamorro González, Patrick Hundsdörfer, Kathrin Hauptmann, Karin Schmelz, Dennis Gürgen, Julian M.M. Rogasch, Anton G. Henssen, Matthias Fischer, Johannes H. Schulte, Cornelia Eckert, Angelika Eggert, Marco Lodrini, Hedwig E. Deubzer   +19 more
openalex   +1 more source

Exploration of the benefits and resistance mechanisms of immunotherapy based on PD-L1 expression, circulating tumor DNA and T-cell receptor profiles in advanced gastric cancer. [PDF]

Cancer Immunol Immunother
Gou M, Qian N, Zhang Y, Yan B, Wang Z, Dai G.   +5 more
europepmc   +1 more source

Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications. [PDF]

J Cancer
Cendra AS, Ospino LR, Pekarek L, Dbouk Y, Chnaiker S, Luengo A, Villamor T, Corralo A, Diaz-Pedrero R, Lopez-Gonzalez L, Saez MA, Alhaddadin MNM, Alonso-Bartolome MB, Casanova-Martín C, Alvarez-Mon M, Rodriguez LG, Barrena-Blázquez S, Ortega MA.   +17 more
europepmc   +1 more source

Cancer in a drop: Liquid biopsy highlights from the World Conference on Lung Cancer (WCLC) 2025. [PDF]

J Liq Biopsy
Ghazali N, Ortega-Franco A, de Miguel-Perez D, Saldanha EF, Venetis K, Pisapia P, Singhal S, Bleiberg BA, Reduzzi C, Borea R.   +9 more
europepmc   +1 more source

Supplementary Table 8 from <i>ERBB2</i>/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer

Gillian Vandekerkhove, Andrew J. Murtha, David C. Müller, Maria Stephenson, Kimia Rostin, Aslı D. Munzur, Carlos Vasquez-Rios, Jussi Nikkola, Joonatan Sipola, Matti Annala, Cameron Herberts, Emily Fung, Jaskirat Atwal, Sadeem Al-Subaie, Karan Parekh, Cecily Q. Bernales, Gráinne Donnellan, Daygen L. Finch, Krista Noonan, Jenny J. Ko, Güliz Özgün, Lucia Nappi, Christian Kollmannsberger, Jean‐Michel Lavoie, Sunil Parimi, Tilman Todenhöfer, Piet Ost, Gang Wang, Peter C. Black, Corinne Maurice‐Dror, Kim N., Bernhard J. Eigl, Alexander W. Wyatt   +32 more
openalex   +1 more source

Unveiling the clinical impact of plasma-only mutations in non-small cell lung cancer: a Korean multicenter experience. [PDF]

Transl Lung Cancer Res
Lee JW, Choi YJ, Kim JS, Kang EJ, Ahn MS, Kim YJ, Yi SY, Lim S, Lee JY, Kim JW, Shin SW, Kim YH.   +11 more
europepmc   +1 more source

Development of a method for detecting ctDNA in patients with non-small cell lung cancer using the RASSF1 methylation marker

S. Y. Smirnou, Antanina Miadzvedz, S. N. Pivavarchyk, T. G. Vakhomchyk, P. E. Karatkevich, H. Subach, Anna Portyanko   +6 more
openalex   +2 more sources

Abstracts

Cancer Science, Volume 117, Issue S1, Page 1-2148, January 2026.
wiley   +1 more source